The third issue of AI in Precision Oncology

Douglas Flora posted on LinkedIn:

“Look what arrived in the mail, Issue 3! Have you checked it out? If you have ideas for articles, reviews, or interesting frontmatter, please reach out.

And thank you to all who’ve already subscribed, contributed, or reached out to your own institutional librarians to add this new title!”         .

Source: Douglas Flora/LinkedIn

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.
As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.